SpringWorks
SpringWorks develops and commercializes clinical drug therapies for the treatment of cancer, oncology and rare genetic diseases.
Business Model:
Revenue: $35M
Employees: 51-200
Industries / Tags:
Detailed SpringWorks Information
Geographic Data
Address: 100 International Drive
City: Baltimore
State: MD
Zip: 21202
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$287M
Raised Total:$515M
Social
Metrics
2,279,655Website Global Rank
8,320Website Monthly Traffic
Twitter Followers
Description
SpringWorks develops and commercializes clinical drug therapies for the treatment of cancer, oncology and rare genetic diseases.
Contact Phone:
+19173308560
Contact Email:
SpringWorks went public on 9/12/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
9/12/2019
IPO Valuation:
$752M
Ticker Symbol:
SWTX
IPO Price:
$18/share
Amount Raised:
$162M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2019 | Series B | 10 | $125M |
GlaxoSmithKline Pfizer Venture Investments LifeArc HBM Healthcare Investments AG Bain Capital Perceptive Advisors Laurion Capital Management ArrowMark Partners OrbiMed Samsara BioCapital Perceptive Advisors Pfizer Venture Investments LifeArc HBM Healthcare Investments AG Bain Capital GlaxoSmithKline Perceptive Advisors Laurion Capital Management ArrowMark Partners OrbiMed Samsara BioCapital Perceptive Advisors |
9/2017 | Series A | 5 | $103M |
Pfizer Venture Investments OrbiMed LifeArc Bain Capital Life Sciences Bain Capital Double Impact Fund |
9/2022 | Post-IPO Equity | 5 | $225M |
Perceptive Advisors Invus Opportunities EcoR1 Capital Deerfield Management Boxer Capital |
3/2019 | Series B | $125M |
Perceptive Advisors OrbiMed Advisors Bain Capital HBM Healthcare Investments Pfizer GlaxoSmithKline |
9/2019 | IPO | $162M |
|
9/2022 | Private Placement | $225M | 10/2020 | Post-IPO Equity | $287.5M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
